ACM
OKUR

ADAR1 Capital Management’s OnKure Therapeutics OKUR Stock Holding History

ADAR1 Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
2,434,941
+1,420,783
+140% +$4.39M 0.59% 46
2025
Q4 		$2.94M Buy
+1,014,158
New +$3.04M 0.22% 82
2025
Q3 		– Sell
-10,000
Closed -$23.9K – 270
2025
Q2 		$23.9K Hold
10,000
– – ﹤0.01% 198
2025
Q1 		$43K Buy
+10,000
New +$56.2K 0.01% 183
2024
Q1 		– Sell
-4,000
Closed -$64K – 292
2023
Q4 		$64K Buy
+4,000
New +$249K 0.02% 106

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ADAR1 Capital Management's OKUR Position: Q1 2026 in Review

ADAR1 Capital Management increased its OnKure Therapeutics (OKUR) stake by 140% in Q1 2026, buying an estimated $4.39M and bringing the position to 2,434,941 shares worth $10.1M. The position accounts for 0.59% of the portfolio, ranked #46.

ADAR1 Capital Management first reported a position in OKUR in Q4 2023 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • ADAR1 Capital Management held 2,434,941 shares of OnKure Therapeutics worth $10.1M as of Q1 2026.
  • ADAR1 Capital Management bought 1,420,783 OnKure Therapeutics shares in Q1 2026, an estimated $4.39M.
  • OnKure Therapeutics made up 0.59% of ADAR1 Capital Management's portfolio in Q1 2026, its #46 holding.
  • ADAR1 Capital Management first reported a position in OnKure Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.